Alternative Titles:
1. Scientific Probiotic Innovation Goes Global: BC99 Earns 2026 NutraIngredients USA Awards Shortlist Honor
2. Tri-Continental Industry Recognition: BC99 Empowers Global Sports Nutrition with Clinically Validated Probiotics
3. New Milestone in International Layout: BC99 Shortlisted for NutraIngredients USA Awards 2026
News Overview
Building on its successive victories at the 2025 NutraIngredients Asia Awards and NutraIngredients Europe Awards in the Ingredient of the Year: Sports Nutrition category, our flagship proprietary probiotic strain Weizmannia (Bacillus) coagulans BC99 has achieved another major industry breakthrough — officially being shortlisted for the2026 NutraIngredients USA Awards. This honor marks BC99’s full recognition across Asia, Europe and North America, covering the world’s three core nutrition ingredient markets, and further consolidates our leading position in global scientific probiotic innovation.
As one of the most authoritative and influential honors in the global dietary supplement and functional nutrition industry, the NutraIngredients USA Awards enters its ninth edition in 2026. With 16 professional evaluation categories and record-breaking global submissions, the awards strictly screen innovative ingredients and solutions with scientific credibility, market potential and industrial value, serving as a core benchmark for measuring the innovation strength of the global nutrition industry. Being shortlisted fully demonstrates the high recognition of BC99’s efficacy, stability and innovative value by the international authoritative industry jury.
Science-Backed Strength, Empowering Upgraded Sports Nutrition
The continuous global recognition of BC99 stems from its rigorous scientific research foundation and outstanding product performance. Different from ordinary nutritional ingredients, this proprietary strain is supported by multiple authoritative clinical studies, with exceptional environmental stability and wide-ranging application compatibility. It can precisely respond to the increasingly diversified and refined demand changes of the global sports nutrition market, providing safe, efficient and clinically verified probiotic nutritional solutions for sports functional products.
This series of tri-continental honors is not only a profound affirmation of BC99’s product strength, but also a powerful interpretation of the future development trend of the functional nutrition industry — clinical validation has become the core competitiveness of high-end nutritional ingredients. In an industry where innovative products are emerging in large numbers, scientific verification and practical efficacy are the essential support for product long-term development and global market layout.
Persisting in Scientific Innovation, Delivering Global Nutritional Value
For a long time, we have adhered to the core philosophy of "transforming scientific research achievements into practical nutritional solutions". From laboratory research and strain optimization to clinical verification and global market promotion, every link takes scientific rigor and practical efficacy as the primary standard. The successive awards in Asia, Europe and the United States prove that our independent innovative probiotic products have fully met the international high-end industry standards and have strong global market competitiveness.
We sincerely gratitude to the persistent dedication of the internal research and development team, the long-term strategic support of global partners, and the consistent trust of customers worldwide. In the future, we will continue to focus on clinical validated probiotic innovation, deeply explore the application value of probiotics in sports nutrition and functional food fields, and launch more scientific, safe and efficient nutritional ingredient solutions to empower the high-quality development of the global functional nutrition industry.